Katie Payne Takes the Helm as Chief External Affairs Officer at Prime Therapeutics Katie Payne has been appointed Chief External Affairs Officer at Prime Therapeutics. With extensive experience in health policy, she aims to enhance communications and advocacy efforts.

Katie Payne Takes the Helm as Chief External Affairs Officer at Prime Therapeutics #United_States #Health_Policy #Eagan #Prime_Therapeutics #Katie_Payne

Prime Therapeutics Endorses New FDA Guidelines for Biosimilars Market Integration Prime Therapeutics has expressed strong support for the FDA's recent biosimilar recommendations aimed at facilitating faster and cost-effective drug access for patients.

Prime Therapeutics Endorses New FDA Guidelines for Biosimilars Market Integration #United_States #FDA #Eagan #Biosimilars #Prime_Therapeutics

Prime Therapeutics and Sempre Health Collaborate to Enhance Patient Affordability with Innovative Pricing Model Prime Therapeutics and Sempre Health are expanding their behavior-based pricing model nationwide, aimed at improving medication affordability and adherence for patients across the U.S.

Prime Therapeutics and Sempre Health Collaborate to Enhance Patient Affordability with Innovative Pricing Model #United_States #San_Francisco #Healthcare_Innovation #Prime_Therapeutics #Sempre_Health

Prime Therapeutics Unveils Groundbreaking Insights at AMCP Nexus 2025 At AMCP Nexus 2025, Prime Therapeutics presents vital research on managed care pharmacy insights to enhance health care affordability and access.

Prime Therapeutics Unveils Groundbreaking Insights at AMCP Nexus 2025 #United_States #National_Harbor,_Maryland #GLP-1_drugs #Prime_Therapeutics #AMCP_Nexus

New Research Reveals Low Long-Term Persistence in GLP-1 Drug Use for Obesity Treatment Prime Therapeutics' recent study indicates that only 8% of patients continue with GLP-1 drugs for obesity treatment after three years, highlighting ongoing challenges.

New Research Reveals Low Long-Term Persistence in GLP-1 Drug Use for Obesity Treatment #USA #GLP-1 #Eagan #Obesity_Treatment #Prime_Therapeutics